Mostrar el registro sencillo

dc.contributor.authorVerla, Wesleyes_ES
dc.contributor.authorBarratt, Racheles_ES
dc.contributor.authorChan, Garsones_ES
dc.contributor.authorDimitropoulos, Konstantinoses_ES
dc.contributor.authorEsperto, Francescoes_ES
dc.contributor.authorYuhong, Yuanes_ES
dc.contributor.authorGreenwell, Tamsines_ES
dc.contributor.authorLumen, Nicolaases_ES
dc.contributor.authorMartins, Franciscoes_ES
dc.contributor.authorOsman, Nadires_ES
dc.contributor.authorPloumidis, Achilleses_ES
dc.contributor.authorRiechardt, Silkees_ES
dc.contributor.authorWaterloos, Marjanes_ES
dc.contributor.authorCampos Juanatey, Felix es_ES
dc.contributor.authorEuropean Association of Urology Urethral Stricture Guidelines Paneles_ES
dc.contributor.otherUniversidad de Cantabriaes_ES
dc.date.accessioned2023-10-04T16:29:52Z
dc.date.available2023-10-04T16:29:52Z
dc.date.issued2023es_ES
dc.identifier.issn2666-1691es_ES
dc.identifier.issn2666-1683es_ES
dc.identifier.urihttps://hdl.handle.net/10902/30129
dc.description.abstractContext Intermittent self-dilatation (ISD) is a therapeutic strategy used to stabilise a urethral stricture and postpone or avoid further treatment. Adding corticosteroids to this mode of management might further enhance its outcomes by downregulation of collagen deposition and excessive scar tissue formation. Objective To explore whether a course of ISD with topical corticosteroids is superior at stabilising urethral stricture disease in men and improving functional outcomes over a course of ISD alone. Evidence acquisition This systematic review and meta-analysis was undertaken by the European Association of Urology Urethral Strictures Guideline Panel according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines (CRD42021256744). The primary benefit outcome was successful stabilisation of the urethral stricture. Treatment-related complications were the primary harm outcome. Evidence synthesis In total, 978 records were screened for eligibility, ultimately leading to five included studies, all randomised controlled trials, comprising 250 patients, of whom 124 underwent a course of ISD with corticosteroids and 126 underwent a course of ISD alone, all after direct vision internal urethrotomy (DVIU). Successful stabilisation of the stricture was achieved in 77% and 64% of patients in the group with and without corticosteroids, respectively (p=0.04). No extra complications related to the addition of corticosteroids to the ISD regimen were reported. The risk of bias of the included studies was generally unclear to high. Conclusions Based on the currently available data, a course of ISD with topical corticosteroids appears to be safe and superior at stabilising a urethral stricture after DVIU in the short term to a course of ISD alone. However, given the unclear to high risk of bias in the included studies, further high-quality studies are needed to fully underpin thises_ES
dc.format.extent11 p.es_ES
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.sourceEuropean urology open sciencees_ES
dc.subject.otherIntermittent self-dilatationes_ES
dc.subject.otherCorticosteroidses_ES
dc.subject.otherUrethral stricture diseasees_ES
dc.subject.otherFunctional outcomeses_ES
dc.subject.otherMenes_ES
dc.titleIs a course of intermittent self-dilatation with topical corticosteroids superior at stabilising urethral stricture disease in men and improving functional outcomes over a course of intermittent self-dilatation alone? A systematic review and meta-analysises_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publisherVersionhttps://doi.org/10.1016/j.euros.2023.01.011es_ES
dc.rights.accessRightsopenAccesses_ES
dc.identifier.DOI10.1016/j.euros.2023.01.011es_ES
dc.type.versionpublishedVersiones_ES


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo

Attribution-NonCommercial-NoDerivatives 4.0 InternationalExcepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 International